Epidemiology of Brain Tumors, Methods Mol Biol, vol.472, pp.323-342, 2009. ,
DOI : 10.1007/978-1-60327-492-0_14
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005. ,
DOI : 10.1056/NEJMoa043330
Tumorigenesis of Chemotherapeutic Drug-Resistant Cancer Stem-Like Cells in Brain Glioma, Stem Cells and Development, vol.16, issue.5, pp.837-847, 2007. ,
DOI : 10.1089/scd.2007.0006
Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited, STEM CELLS, vol.11, issue.6, pp.639-648, 2010. ,
DOI : 10.1002/stem.318
New Perspectives in Glioma Immunotherapy, Current Pharmaceutical Design, vol.17, issue.23, pp.2439-2467, 2011. ,
DOI : 10.2174/138161211797249206
Cellular immunity in the treatment of brain tumors, Clin Neurosurg, vol.51, pp.132-139, 2004. ,
EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme, Molecular Cancer Research, vol.3, issue.10, pp.541-551, 2005. ,
DOI : 10.1158/1541-7786.MCR-05-0056
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma, Journal of Clinical Oncology, vol.28, issue.31, pp.4722-4729, 2010. ,
DOI : 10.1200/JCO.2010.28.6963
) and Their O-Acetylated Derivatives, Hybridoma, vol.16, issue.4, pp.307-316, 1997. ,
DOI : 10.1089/hyb.1997.16.307
Role of tumor-associated gangliosides in cancer progression, Biochimie, vol.85, issue.3-4, pp.455-463, 2003. ,
DOI : 10.1016/S0300-9084(03)00006-3
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy, FEBS Letters, vol.3, issue.2, pp.288-297, 2014. ,
DOI : 10.1016/j.febslet.2013.11.030
Immunohistochemically visualized localisation of gangliosides Glac2 (GD3) and Gtri2 (GD2) in cells of human intracranial tumors, Experimental and Toxicologic Pathology, vol.52, issue.4, pp.277-285, 2000. ,
DOI : 10.1016/S0940-2993(00)80046-9
A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity, PLoS ONE, vol.38, issue.9, p.25220, 2011. ,
DOI : 10.1371/journal.pone.0025220.s006
Complement-Mediated Mechanisms in Anti-GD2 Monoclonal Antibody Therapy of Murine Metastatic Cancer, Cancer Research, vol.65, issue.22, pp.10562-10568, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-1894
Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice, Molecular Immunology, vol.42, issue.11, pp.1311-1319, 2005. ,
DOI : 10.1016/j.molimm.2004.12.018
Chimeric Antigen Receptor???Modified T Cells for Acute Lymphoid Leukemia, New England Journal of Medicine, vol.368, issue.16, pp.1509-1518, 2013. ,
DOI : 10.1056/NEJMoa1215134
A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies, International Journal of Cancer, vol.50, issue.2, pp.197-201, 1992. ,
DOI : 10.1002/ijc.2910500207
Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo, Cancer Letters, vol.333, issue.2, 2013. ,
DOI : 10.1016/j.canlet.2013.01.032
EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss, Clinical Cancer Research, vol.20, issue.4, pp.972-984, 2014. ,
DOI : 10.1158/1078-0432.CCR-13-0709
Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma, Clin Cancer Res, vol.4, pp.2135-2139, 1998. ,
Rapid colorimetric assay for cell growth and survival, Journal of Immunological Methods, vol.89, issue.2, pp.271-277, 1986. ,
DOI : 10.1016/0022-1759(86)90368-6
Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores, Journal of Immunological Methods, vol.258, issue.1-2, pp.183-191, 2001. ,
DOI : 10.1016/S0022-1759(01)00474-4
Long-Term Preservation of Antibody-Dependent Cellular Cytotoxicity (ADCC) of Natural Killer Cells Amplified In Vitro From the Peripheral Blood of Breast Cancer Patients After Chemotherapy, Journal of Immunotherapy, vol.29, issue.1, pp.53-60, 2006. ,
DOI : 10.1097/01.cji.0000175686.13368.5c
Induction of polyoma specific transplantation antigenicity in moloney leukemia cells, Experimental Cell Research, vol.40, issue.1, pp.208-212, 1965. ,
DOI : 10.1016/0014-4827(65)90319-8
A biomathematical approach to clinical tumor growth, Cancer, vol.10, issue.6, pp.1272-1294, 1961. ,
DOI : 10.1002/1097-0142(196111/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H